Published in Amyotroph Lateral Scler on June 01, 2009
Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain (2012) 3.43
TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol (2010) 2.81
Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.08
Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol (2014) 1.88
Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol (2009) 1.85
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain (2012) 1.67
The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med (2012) 1.66
Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology (2010) 1.53
C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology (2015) 1.52
Can MRI screen for CSF biomarkers in neurodegenerative disease? Neurology (2012) 1.52
Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol (2011) 1.48
Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. Neurol Sci (2010) 1.44
ALS-Plus syndrome: non-pyramidal features in a large ALS cohort. J Neurol Sci (2014) 1.44
Extensive genetics of ALS: a population-based study in Italy. Neurology (2012) 1.39
Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol (2010) 1.38
Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol (2009) 1.26
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.21
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol (2014) 1.21
FTD and ALS: a tale of two diseases. Curr Alzheimer Res (2011) 1.12
Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging (2011) 1.11
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol (2014) 1.08
Autophagy and neuronal cell death in neurological disorders. Cold Spring Harb Perspect Biol (2012) 1.08
Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations. Arch Neurol (2010) 1.06
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol (2014) 1.04
Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals. Patient Prefer Adherence (2012) 1.00
Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects. Acta Neuropathol (2012) 0.99
On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog Neurobiol (2011) 0.95
Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci (2014) 0.93
Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations. PLoS One (2014) 0.91
Development and validation of pedigree classification criteria for frontotemporal lobar degeneration. JAMA Neurol (2013) 0.91
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging (2014) 0.90
Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 0.89
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging (2015) 0.89
Deficits in concept formation in amyotrophic lateral sclerosis. Neuropsychology (2012) 0.88
Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One (2013) 0.87
Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Alzheimers Res Ther (2012) 0.87
ALS and Frontotemporal Dysfunction: A Review. Neurol Res Int (2012) 0.86
Some difficult decisions in ALS/MND. Amyotroph Lateral Scler (2010) 0.85
Deficits in sentence expression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.85
Narrative discourse deficits in amyotrophic lateral sclerosis. Neurology (2014) 0.84
Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research. Neural Plast (2012) 0.83
Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol (2013) 0.83
Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis. Dement Geriatr Cogn Dis Extra (2013) 0.83
A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol (2017) 0.83
The function of RNA-binding proteins at the synapse: implications for neurodegeneration. Cell Mol Life Sci (2015) 0.83
Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes. Neuropathol Appl Neurobiol (2013) 0.82
State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener (2015) 0.81
Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China. J Neurol (2014) 0.81
Diffusion tensor tract-specific analysis of the uncinate fasciculus in patients with amyotrophic lateral sclerosis. Neuroradiology (2010) 0.81
Action verb comprehension in amyotrophic lateral sclerosis and Parkinson's disease. J Neurol (2014) 0.81
Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS. Neurology (2012) 0.81
A pilot study of the prevalence of psychiatric disorders in PLS and ALS. Amyotroph Lateral Scler (2010) 0.81
The Relationship between Depressive Symptoms, Disease State, and Cognition in Amyotrophic Lateral Sclerosis. Front Psychol (2012) 0.81
Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Neurotherapeutics (2015) 0.81
What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives. Patient Prefer Adherence (2012) 0.81
Impaired cognitive flexibility in amyotrophic lateral sclerosis. Cogn Behav Neurol (2015) 0.81
Structural and functional hallmarks of amyotrophic lateral sclerosis progression in motor- and memory-related brain regions. Neuroimage Clin (2014) 0.81
Writing errors as a result of frontal dysfunction in Japanese patients with amyotrophic lateral sclerosis. J Neurol (2010) 0.81
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology (2016) 0.80
Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders. Neurology (2014) 0.80
Extramotor damage is associated with cognition in primary lateral sclerosis patients. PLoS One (2013) 0.80
Motor neuron disease and frontotemporal dementia: One, two, or three diseases? Ann Indian Acad Neurol (2010) 0.79
Amyotrophic lateral sclerosis: applications of stem cells - an update. Stem Cells Cloning (2010) 0.78
The Mental Status Examination in Patients With Suspected Dementia. Continuum (Minneap Minn) (2016) 0.78
Cognitive Impairment in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis. PLoS One (2015) 0.78
Different Frontal Involvement in ALS and PLS Revealed by Stroop Event-Related Potentials and Reaction Times. Front Aging Neurosci (2013) 0.78
Microstructural white matter changes underlying cognitive and behavioural impairment in ALS--an in vivo study using DTI. PLoS One (2014) 0.78
Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy. Acta Neuropathol Commun (2016) 0.78
Executive dysfunction predicts social cognition impairment in amyotrophic lateral sclerosis. J Neurol (2015) 0.78
Syntactic comprehension in patients with amyotrophic lateral sclerosis. Behav Neurol (2014) 0.78
Prospective memory tasks: a more sensitive method for screening cognitive impairment in ALS? BMC Neurol (2012) 0.78
A role for ubiquilin 2 mutations in neurodegeneration. Nat Rev Neurol (2011) 0.78
Diffusion tensor MRI changes in gray structures of the frontal-subcortical circuits in amyotrophic lateral sclerosis. Neurol Sci (2014) 0.78
Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions. Neuroimage Clin (2013) 0.78
Action processing and mirror neuron function in patients with amyotrophic lateral sclerosis: an fMRI study. PLoS One (2015) 0.78
The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population. PLoS One (2016) 0.78
Body mass index delineates ALS from FTD: implications for metabolic health. J Neurol (2014) 0.77
A Systematic Review and Meta-Analysis of the Functional MRI Investigation of Motor Neuron Disease. Front Neurol (2015) 0.77
Neuropsychological investigation in Chinese patients with progressive muscular atrophy. PLoS One (2015) 0.77
Working Memory Network Changes in ALS: An fMRI Study. Front Neurosci (2016) 0.77
Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). PLoS One (2016) 0.77
Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology (2016) 0.77
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study. BMJ Open (2015) 0.77
Syntactic processing as a marker for cognitive impairment in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2015) 0.77
Cognition, behavior, and respiratory function in amyotrophic lateral sclerosis. ISRN Neurol (2012) 0.77
Frontotemporal Dementias. Continuum (Minneap Minn) (2016) 0.77
Modeling ALS and FTD with iPSC-derived neurons. Brain Res (2015) 0.77
Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures. Front Hum Neurosci (2013) 0.77
An eye-tracking controlled neuropsychological battery for cognitive assessment in neurological diseases. Neurol Sci (2017) 0.77
The frontotemporal syndrome of ALS is associated with poor survival. J Neurol (2016) 0.76
Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state. Eur J Neurol (2016) 0.76
Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis. Front Aging Neurosci (2015) 0.76
Heritability in frontotemporal dementia: more missing pieces? J Neurol (2014) 0.76
Voxel-Wise Meta-Analysis of Gray Matter Changes in Amyotrophic Lateral Sclerosis. Front Aging Neurosci (2016) 0.76
Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study. PLoS One (2016) 0.76
A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol (2017) 0.75
Cognitive reserve in frontotemporal degeneration: Neuroanatomic and neuropsychological evidence. Neurology (2016) 0.75
Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes. Acta Neuropathol Commun (2016) 0.75
Microstructural Correlates of Emotional Attribution Impairment in Non-Demented Patients with Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.75
Development of patient decision support tools for motor neuron disease using stakeholder consultation: a study protocol. BMJ Open (2016) 0.75
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (2008) 14.09
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2007) 3.93
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol (2010) 3.61
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A (2007) 3.32
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ (2004) 3.29
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord (2007) 2.85
Amyotrophic lateral sclerosis. Orphanet J Rare Dis (2009) 2.76
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci (2007) 2.75
Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia (2013) 2.70
Bilingualism as a protection against the onset of symptoms of dementia. Neuropsychologia (2006) 2.27
Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet (2009) 2.22
Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol (2009) 2.20
Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry (2012) 2.07
Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2009) 2.03
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2009) 1.93
How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract (2007) 1.91
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Multiple biological pathways link cognitive lifestyle to protection from dementia. Biol Psychiatry (2011) 1.79
Delaying the onset of Alzheimer disease: bilingualism as a form of cognitive reserve. Neurology (2010) 1.73
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain (2008) 1.72
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. J Neurol Neurosurg Psychiatry (2011) 1.67
Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci (2004) 1.63
Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol (2006) 1.61
Utility-based Quality of Life measures in Alzheimer's disease. Qual Life Res (2006) 1.55
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum Mol Genet (2008) 1.46
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol (2011) 1.40
Emotion comprehension in the temporal variant of frontotemporal dementia. Brain (2002) 1.40
Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum Brain Mapp (2003) 1.38
Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care (2006) 1.31
Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol (2007) 1.30
Neuropathological correlates of late-life depression in older people. Br J Psychiatry (2011) 1.29
Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Hum Genet (2003) 1.29
Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review. BMC Neurol (2006) 1.27
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol (2005) 1.27
Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J Cell Biol (2003) 1.24
The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci. PLoS One (2009) 1.19
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One (2009) 1.19
The contribution of autobiographical significance to semantic memory: evidence from Alzheimer's disease, semantic dementia, and amnesia. Neuropsychologia (2004) 1.17
Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Arch Neurol (2009) 1.17
The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2008) 1.17
Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet (2002) 1.16
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.16
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 1.15
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ (2008) 1.13
DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One (2009) 1.12
Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry (2012) 1.11
Service use and costs for people with headache: a UK primary care study. J Headache Pain (2011) 1.09
The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain (2011) 1.09
Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry (2007) 1.09
A proposed staging system for amyotrophic lateral sclerosis. Brain (2012) 1.08
Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler (2010) 1.08
The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry (2003) 1.07
The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction. Cortex (2011) 1.06
Latent cluster analysis of ALS phenotypes identifies prognostically differing groups. PLoS One (2009) 1.06
Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery. Schizophr Bull (2012) 1.05
Management of psychogenic nonepileptic seizures. Epilepsia (2013) 1.04
p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci (2004) 1.04
TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology (2009) 1.04
A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler (2008) 1.02
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. Neurobiol Aging (2012) 1.02
Nutritional management in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 1.01
Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation. Cortex (2012) 1.01
Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci (2007) 1.00
Clinical efficacy of galvanic skin response biofeedback training in reducing seizures in adult epilepsy: a preliminary randomized controlled study. Epilepsy Behav (2004) 1.00
Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase. J Neurosci (2003) 1.00
The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry (2005) 1.00
Magnetic resonance imaging in frontotemporal dementia shows subcortical atrophy. Dement Geriatr Cogn Disord (2008) 0.99
Radioguided thoracoscopic mediastinal parathyroidectomy with intraoperative parathyroid hormone testing. Ann Thorac Surg (2005) 0.98
Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology (2008) 0.98
Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord (2007) 0.98
Psychological treatments for epilepsy. Cochrane Database Syst Rev (2008) 0.97
Autobiographical memory and patterns of brain atrophy in frontotemporal lobar degeneration. J Cogn Neurosci (2008) 0.97
Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. Am J Psychiatry (2004) 0.96
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial. Amyotroph Lateral Scler (2009) 0.96
Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach. PLoS One (2013) 0.95
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS One (2012) 0.95
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.94
Access to safe water in rural Artibonite, Haiti 16 months after the onset of the cholera epidemic. Am J Trop Med Hyg (2013) 0.94
The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler (2010) 0.94
ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J Biol Chem (2005) 0.94
Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL. Neurology (2007) 0.93
Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Cogn Behav Neurol (2013) 0.93
Influence of sympathetic autonomic arousal on cortical arousal: implications for a therapeutic behavioural intervention in epilepsy. Epilepsy Res (2004) 0.92
Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device. Circ Heart Fail (2013) 0.92
Learning and memory as a function of age in Down syndrome: a study using animal-based tasks. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.92
Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature. J Neurol Neurosurg Psychiatry (2006) 0.91
Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis? Brain (2005) 0.91
Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study. Am J Geriatr Psychiatry (2011) 0.90
Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 0.89
Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging (2002) 0.89